Clinical Trial Update: Biopsy Based Study to Understand Mechanism of Action of Ianalumab in Salivary Glands and Explore Relationships With Clinical Assessments. [Phase 2]

View source ↗

Summary

A completed Phase 2 study evaluating the mechanism of action of ianalumab in the salivary glands of Sjögren's syndrome patients and its relationship to clinical…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sjögren Syndrome

Drugs mentioned

• Ianalumab (ianalumab)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Sjogren Syndrome | Phase 2 | Status: COMPLETED